| Availability: | |
|---|---|
| Quantity: | |
ATX-304 (O-304)
bonanza
26-0715-02
ATX-304, also known as O-304 / O304, is a small-molecule compound commonly referenced in scientific literature as a pan-AMPK activator. Publicly available sources describe its use in studies related to metabolic regulation, glucose homeostasis, lipid metabolism, and organ-protective research models.
Our ATX-304 (O-304) is prepared with attention to product consistency, handling control, and professional supply standards to support research-focused procurement. It is suitable for laboratories, research organizations, specialty chemical buyers, and other professional customers seeking a dependable source of advanced research compounds.
To accommodate different sourcing needs, we can provide tailored specification options together with customized packaging formats. With export-oriented service support and reliable bulk delivery capability, our ATX-304 is positioned for international B2B supply in the research and specialty compound market.
Research-oriented small molecule for professional supply
Commonly referenced as a pan-AMPK activator in public literature
Suitable for laboratory and preclinical project use
Packed for export and international shipment
Bulk supply support for B2B procurement
Custom specification and packaging options available
ATX-304 (O-304) is a research-grade small molecule designed exclusively for laboratory testing and preclinical research. Manufactured following standardized controlled production protocols, this compound adopts export-compliant packaging to guarantee stable quality during long-distance international transportation. We serve global research institutes, professional distributors and B2B purchasers, offering customizable specifications and packaging plans. As a reliable research raw material, it delivers stable performance to support consistent experimental outcomes for scientific study.
Standardized controlled production process ensures stable batch consistency. Every production procedure is strictly monitored and recorded. Each batch undergoes comprehensive quality inspection before delivery, effectively lowering experimental errors caused by inconsistent purity. More than 98% of our batches pass full specification testing to meet rigorous laboratory research standards.
Export-ready packaging adapts to global cross-border logistics. The packaging adopts shockproof, sealed and moisture-resistant materials to prevent contamination or deterioration during sea and land transport. Complete supporting documentation can be provided to simplify customs clearance for overseas bulk buyers and distributors.
Customizable specifications and flexible packaging options are available on demand. We can adjust packing weight, container type and label design according to client experimental scales and sales demands. This tailored service helps both research labs and distributors optimize inventory management and experimental arrangements.
Stable bulk supply capacity supports long-term B2B cooperation. We maintain adequate stock for regular orders and arrange prioritized production for large bulk demands. Reliable lead time avoids interruptions to ongoing laboratory projects, preclinical trials and global distribution businesses of our partners.
Professional service for global research institutions and specialty distributors. Our team provides efficient communication on technical inquiries, order progress and after-sales support. We streamline cross-border procurement workflows to help overseas buyers reduce procurement cycles and operational costs.
Basic laboratory scientific research ATX-304 (O-304) can be applied in cell experiments, molecular mechanism exploration and other fundamental academic research. Its stable quality helps researchers obtain repeatable experimental data, supporting data collation for academic papers and internal research reports.
Preclinical research studies This research-grade small molecule meets the material requirements of preclinical efficacy evaluation and safety testing. Biotech laboratories can use it to carry out preliminary pharmacological research and related biological assessment to advance research project progress.
Global B2B procurement for research raw materials Specialty distributors and biotech enterprises can purchase ATX-304 (O-304) in bulk. Standard export packaging and complete qualification materials facilitate cross-border transportation, customs clearance and secondary distribution in international markets.
Q1: How long is mass production lead time?
A: In-stock items ship within 3–5 working days after deposit. Custom formulas or out-of-stock goods take 7–12 working days. We prioritize production for urgent orders with tight deadlines.
Q2: What is the shelf life and storage method?
A: Unopened shelf life is 24 months. Please seal tightly and store in cool, dry, shaded place below 25℃, avoid direct sunlight and damp environment. After opening, seal and refrigerate, finish within 3 months.
Q3: What’s your after-sales policy for defective goods?
A: Please provide clear photos, videos and batch COA within 7 days after receiving goods. Our QC team will verify quickly. If quality problems are caused by our production, we offer free re-delivery, replacement or full refund, and bear all related freight costs.
1. What is ATX-304 (O-304)?
ATX-304, also written as O304 or O-304, is described in public sources as a pan-AMPK activator used in metabolic and preclinical research settings.
2. What kinds of projects is it commonly associated with?
Published studies have linked ATX-304 to research involving glucose regulation, fatty liver disease models, metabolic switching, and kidney injury models.
3. Is ATX-304 mainly a consumer supplement ingredient?
Based on the sources reviewed, it is more commonly presented as a research or development-stage compound rather than a standard finished consumer ingredient.
4. Do you support bulk supply and export packaging?
Yes, bulk B2B supply and export-oriented packaging options can be arranged according to customer requirements.
5. Has ATX-304 been studied in humans?
Public sources indicate early human trials and report that the compound was found safe and well tolerated in studies with exposure up to four weeks, but the public literature and company materials still position it as an active development-stage compound.